From: The emerging roles of N6-methyladenosine RNA methylation in human cancers
m6A regulators | Cancer type | Role in cancer | Genes involved | Mechanism | Reference |
---|---|---|---|---|---|
Writers | |||||
METTL3 | GBCa | Oncogene | SOX2 | Enhances the stemness of GSCs by facilitating expression of SOX2 | [58] |
SRSFs | Enhances the stemness of GSCs by increasing the NMD of SRSFs in YTHDC1-dependent way | [59] | |||
Antioncogene | ADAM19 | Inhibits the stemness of GSCs by promoting the expression of ADAM19 | |||
LC | Oncogene | EGFR TAZ MK2 DNMT3 | Enhances the stemness of LC stem cells by promoting expression of EGFR, TAZ, MK2 and DNMT3 | [53] | |
VASH1 | Promotes brain metastasis of LC by inhibiting the expression of VASH1 via up-regulated miR-143-3p | [70] | |||
HCC | Oncogene | SOCS2 | Increases the decay of tumor suppressor SOCS2 via YTHDF2 in m6A-dependent way | [76] | |
Snail | Promotes the progress of EMT by regulating the expression of Snail in YTHDC1-dependent way | [77] | |||
HDGF | Up-regulates the level of LINC00958 and promotes the expression of HDGF by inhibiting miR-3619-5p | [78] | |||
GC | Oncogene | MYC | Enhances the expression of oncogene MYC | [86] | |
Bcl2 | Inhibits the apoptosis of GC cells by up-regulating the expression of Bcl2 via competitive inhibition with Bax | [10] | |||
SEC62 | Promotes the expression of SEC62 with the help of IGF2BP1 | [88] | |||
HDFG | Promotes the expression of HDFG with the help of IGF2BP3 | [89] | |||
CRCa | Oncogene | SOX2 | Enhances the proliferation of CRC cells by facilitating expression of SOX2 in a m6A-IGF2BP2-dependent mechanism | ||
Antioncogene | ? | Inhibits the proliferation, metastasis in CRC by suppressing the p38/ERK signaling pathways | [94] | ||
ccRCC | Antioncogene | NANOG | Inhibits the stemness of ccRCC cells by reducing the expression of NANOG | [103] | |
VHL | Inhibits the stemness of ccRCC cells by up-regulating the expression of VHL and reducing the level of HIF-α | [103] | |||
BC | Oncogene | SETD7 KLF4 | Facilitates the degradation of tumor suppressor m6A-modified SETD7 mRNA and m6A-modified KLF4 mRNA in YTHDF2-dependent way | [110] | |
ITGA6 | Promotes the expression of oncogene ITGA6 in YTHDF1 and YTHDF3 dependent way | [111] | |||
EC | Antioncogene | PHLPP2 mTORC | Promotes the excessive activation of AKT by reducing expression of PHLPP2 and increasing expression of mTORC | [116] | |
OC | Oncogene | RHPN1-AS1 | Promotes the expression of RHPN1-AS1 and activates FAK/PI3K/Akt pathway | [117] | |
Breast cancera | Antioncogene | NANOG | Inhibits the stemness of BCSCs by reducing the translation of NANOG | [119] | |
KLF4 | Inhibits the stemness of BCSCs by reducing the translation of KLF4 | [119] | |||
Oncogene | HBXIP | Enhances the stemness of BCSCs by increasing the expression of HBXIP | [120] | ||
MAGI3 | switches the role of MAGI3 from antioncogene to an oncogene in m6A-dependent way | [121] | |||
Bcl2 | Promotes the expression of Bcl2 | [122] | |||
AML | Oncogene | SP1 c-MYC | Promotes the expression of SP1 and enhance its function to activate oncogene c-MYC | [127] | |
Oncogene | Bcl2 PTEN | Promotes the proliferation of leukemia cells and inhibits their differentiation by enhancing expression of Bcl2, PTEN | [128] | ||
METTL14 | GBC | Antioncogene | ADAM19 | Inhibits the stemness of GSCs by promoting the expression of ADAM19 | |
HCCa | Antioncogene | miR126 | Inhibits the metastasis and relapse of HCC by promoting the mature of tumor suppressor miR126 with the aid of DGCR8 | [83] | |
CRC | Antioncogene | Inhibits the proliferation and metastasis of CRC by up-regulating the m6A level of lncRNA XIST and facilitates its degradation | [95] | ||
ccRCC | Antioncogene | NANOG | Inhibits the stemness of ccRCC cells by reducing the expression of NANOG | [103] | |
VHL | Inhibits the stemness of ccRCC cells by up-regulating the expression of VHL and reducing the level of HIF-α | [103] | |||
BC | Antioncogene | Notch-1 | Inhibits the self-renewal of TICs by reducing the expression of Notch-1 | [112] | |
AML | Oncogene | MYB MYC | Promotes the expression of MYB and MYC | [129] | |
WTAP | HCC | Oncogene | ETS1 | Inhibits the expression of HCC suppressor ETS1 with the help of HuR | [79] |
ccRCC | Oncogene | CDK2 | Promotes the metastasis by increasing the expression of CDK2 | [8] | |
VIRMA | HCC | Oncogene | ID2 | Promotes the migration by decreasing the expression of ID2 | [80] |
GATA3 | Promotes decay of GATA3 by inducing the separation of HuR | [81] | |||
Prostate cancer | Oncogene | CCAT1, CCAT2 | Enhances malignant phenotype and the translation of lncRNAs CCAT1, CCAT2 | [106] | |
Breast cancer | Oncogene | CDK1 | Enhances the expression of CDK1 | [123] | |
Erasers | |||||
FTO | GBC | Oncogene | ADAM19 | Enhances the stemness of GSCs by promoting the expression of ADAM19 | [58] |
LCa | Oncogene | LAMC2 TSP1 VGF ITGα11 PCSK9 | Enhances the stemness of lung cancer stem cells by promoting expression of LAMC2, TSP1, VGF, ITGα and PCSK9 | [67] | |
HCC | Oncogene | PK2 | Promotes the expression of PK2 by demethylation | [82] | |
Pancreatic cancer | Oncogene | MYC,bHLH-TF | Promotes the proliferation of pancreatic cancer cells by increasing expression of MYC, bHLH-TF | [98] | |
ccRCC | Antioncogene | ? | ? | [104] | |
CC | Oncogene | ? | Enhances the resistance to chemoradiotherapy by inhibiting the translation of β-catenin mRNA | [115] | |
AML | Oncogene | RARα ASB2 | Inhibits differentiation of AML cells and promotes resistant to ATRA by enhancing the expression of RARα and ASB2 | [126] | |
Oncogene | MYC CRBPA | Reduces the degradation of MYC and CRBPA in YTHDF2-dependent way | [130] | ||
ALKBH5 | GBC | Oncogene | ADAM19 FOXM1 | Enhances the stemness of GSCs by promoting the expression of ADAM19 and FOXM1 | |
LC | Oncogene | FOXM1 | Enhances the stemness of GSCs by promoting the expression of FOXM1 | ||
GC | Oncogene | NEAT1 | Promotes the metastasis by increasing the expression of NEAT1 | [90] | |
ccRCCa | Oncogene | NANOG | Promotes the stemness of ccRCC cells by increasing the expression of NANOG | [103] | |
VHL | Promotes the stemness of ccRCC cells by silencing VHL and increases the level of HIF-α | [103] | |||
Antioncogene | ? | ? | [104] | ||
CC | Antioncogene | GAS5 | Inhibits the decay of tumor suppressor GAS5 by interacting with lncRNA GAS5-AS1 in YTHDF2-dependent way | [114] | |
Breast cancer | Oncogene | NANOG | Enhances the stemness of BCSCs by promoting expression of NANOG | ||
KLF4 | Enhances the stemness of BCSCs by promoting the expression of KLF4 | [119] | |||
AMLa | Oncogene | TACC3 AXL | Promotes self-renewal of LSCs/LICs via ALKBH5/m6A/TACC3 axis and KDM4C/ALKBH5/AXL axis | ||
Antioncogene | TP53 | Inhibits the mutation of TP53 | [131] | ||
Readers | |||||
YTHDF1 | CRC | Oncogene | ? | Promotes the proliferation of CRC cells by activating the Wnt/beta-catenin pathway | [96] |
BC | Oncogene | ITGA6 | Promotes the translation of ITGA6 by enhancing its stability | [111] | |
EC | Antioncogene | PHLPP2 | Keeps the balance of AKT pathway by promoting the expression of PHLPP2 | [116] | |
YTHDF2 | HCCa | Oncogene | SOCS2 | Facilitates the degradation of tumor suppressor m6A-modified SOCS2 mRNA and down-regulate its expression | [76] |
Antioncogene | IL11 SERPINE2 | Improves the microenvironment by accelerating the degradation of IL11, SERPINE2 | [84] | ||
CRC | Antioncogene | XIST | Inhibits the proliferation and metastasis of CRC by facilitating the degradation of m6A-modified lncRNA XIST | [95] | |
Pancreatic cancer | Oncogene | ? | Promotes the progression of EMT by regulating the YAP signaling pathway and inhibits the metastasis of pancreatic cancer | [100] | |
Prostate cancer | Oncogene | ? | Promotes the proliferation of prostate cancer cells and accelerates metastasis by? | [107] | |
CC | Oncogene | GAS5 | Promotes the degradation of tumor suppressor GAS5 | [114] | |
EC | Antioncogene | mTORC | Keeps the balance of AKT pathway by promoting the decay of mTORC | [116] | |
AML | Antioncogene | MYC CRBPA | Accelerates the degradation of MYC CRBPA | [130] | |
YTHDF3 | BC | Oncogene | ITGA6 | Promotes the translation of ITGA6 by enhancing its stability | [111] |
CRC | Oncogene | Facilitates the progression of CRC by the negative function loop of lncRNA GAS5-YAP-YTHDF3 axis | [97] | ||
YTHDC1 | GBC | Oncogene | SRSFs | Enhances the stemness of GSCs by promoting the decay of m6A-modified SRSFs mRNA | [59] |
Oncogene | Snail | Promotes the progression of EMT by regulating the expression of Snail | [77] | ||
IGF2BPs | HCC | Oncogene | MYC | Promotes the expression of oncogene MYC by enhcancing its stability | [51] |
GC | Oncogene | SEC62 | Promotes the translation of m6A-modified SEC62 mRNA by enhancing its stability | [88] | |
HDFG | Promotes the translation of m6A-modified HDGF mRNA by enhancing its stability | [89] | |||
Pancreatic cancer | Oncogene | DANCR | Enhances the stemness of pancreatic cancer cells by up-regulating the expression of DANCR | [99] | |
METTL3 | LC | Oncogene | BRD4 | Promotes the expression of oncogene BRD4 by interacting with eIF3h | [71] |